Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma.
Forty-one patients with various forms of systemic sclerosis (scleroderma) and positive antinuclear antibodies of nucleolar (ten patients), speckled (eleven patients), or centromere pattern (twenty patients) were selected for study of immune complexes by the radioisotope labeled Clq binding and the radioisotope labeled protein A binding methods. The presence of immune complexes was found by the Clq binding assay in sixteen patients (39%) and by a protein A binding assay in eight patients (20%). Overall, 46% of patients (19/41) had immune complexes. A lower incidence of organ involvement and fewer positive results in the screening of serum immune complexes were observed in patients with centromere antibody (35%) than in patients with nucleolar (60%) or speckled pattern (55%). Patients with immune complexes had higher frequencies of kidney, heart, and muscle involvement and digital ulceration than did patients with no detectable immune complexes, but the differences were not statistically significant. Diffuse skin involvement was not related to the presence of immune complexes.
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000302:isolation & purification*; D000936:Antigen-Antibody Complex / Q000302:isolation & purification*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000276:immunology*; D002466:Cell Nucleolus / Q000276:immunology*; D002503:Centromere / Q000276:immunology*; D002875:Chromosomes / Q000276:immunology*; D003937:Diagnosis, Differential; D006801:Humans; D007105:Immune Complex Diseases / Q000175:diagnosis / Q000276:immunology*; D007158:Immunologic Techniques; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology; D012867:Skin / Q000648:ultrastructure
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex